Insider Transactions in Q2 2025 at Acrivon Therapeutics, Inc. (ACRV)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.89%
|
$19,904
$1.15 P/Share
|
May 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.5%
|
$184
$1.14 P/Share
|
May 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.24%
|
$99
$1.14 P/Share
|
May 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
491
-0.16%
|
$491
$1.14 P/Share
|
May 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,766
-2.61%
|
$59,766
$1.14 P/Share
|
May 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.91%
|
$613
$1.14 P/Share
|
May 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-2.44%
|
$403
$1.14 P/Share
|
May 01
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
298,886
-8.78%
|
$298,886
$1.34 P/Share
|
Apr 30
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
437,881
-11.4%
|
$437,881
$1.41 P/Share
|
Apr 29
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-6.11%
|
$250,000
$1.41 P/Share
|
Apr 28
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
215,283
-5.0%
|
$215,283
$1.56 P/Share
|
Apr 25
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,054,669
-19.67%
|
$1,054,669
$1.95 P/Share
|
Apr 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.51%
|
$558
$1.81 P/Share
|